The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
For a limited time only, Cleanroom Technology Conference offers early bird ticket rates for the annual conference due to take place in May 2024